GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kangmei Pharmaceutical Co Ltd (SHSE:600518) » Definitions » Long-Term Capital Lease Obligation

Kangmei Pharmaceutical Co (SHSE:600518) Long-Term Capital Lease Obligation : ¥169 Mil (As of Sep. 2024)


View and export this data going back to 2001. Start your Free Trial

What is Kangmei Pharmaceutical Co Long-Term Capital Lease Obligation?

Kangmei Pharmaceutical Co's Long-Term Capital Lease Obligation for the quarter that ended in Sep. 2024 was ¥169 Mil.

Kangmei Pharmaceutical Co's quarterly Long-Term Capital Lease Obligation declined from Mar. 2024 (¥187 Mil) to Jun. 2024 (¥176 Mil) and declined from Jun. 2024 (¥176 Mil) to Sep. 2024 (¥169 Mil).

Kangmei Pharmaceutical Co's annual Long-Term Capital Lease Obligation increased from Dec. 2021 (¥153 Mil) to Dec. 2022 (¥199 Mil) but then declined from Dec. 2022 (¥199 Mil) to Dec. 2023 (¥188 Mil).


Kangmei Pharmaceutical Co Long-Term Capital Lease Obligation Historical Data

The historical data trend for Kangmei Pharmaceutical Co's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kangmei Pharmaceutical Co Long-Term Capital Lease Obligation Chart

Kangmei Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Long-Term Capital Lease Obligation
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 140.64 153.22 199.13 188.16

Kangmei Pharmaceutical Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Long-Term Capital Lease Obligation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 195.86 188.16 186.62 176.46 169.19

Kangmei Pharmaceutical Co  (SHSE:600518) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

Kangmei Pharmaceutical Co Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Kangmei Pharmaceutical Co's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.


Kangmei Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
Taike Road, Xiameilin, Futian District, Guangdong, Shenzhen, CHN, 518000
Kangmei Pharmaceutical Co Ltd is a pharmaceutical company engaged in the trading of Chinese herbal medicines, production and sales of Chinese herbal medicine slices, Chinese patent medicine preparations, health foods, chemical drugs and medical devices, modern pharmaceutical logistics system.
Executives
Xu Dong Jin Director
Li Jian Hua senior management
Qiu Xi Wei Director
Wang Min senior management
Peng Qin senior management
Ma Xing Tian Director
Lin Guo Xiong senior management
Zhuang Yi Qing senior management
Wen Shao Sheng Supervisors

Kangmei Pharmaceutical Co Headlines

No Headlines